Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Rubinstein

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15Chris Ramsey, Mark P Rubinstein, David M Kim, et al.
The Journal of Experimental Medicine|April 11, 2007
Antiviral CD4+ memory T cells are IL-15 dependentJared F Purton, Joyce T Tan, Mark P Rubinstein, et al.
Cancer|January 10, 2018
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicineJenny M Riley, Ashley W Cross, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cellsMark P Rubinstein, Andre N Kadima, Mohamed L Salem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cellJeffrey J Roszkowski, David C Yu, Mark P Rubinstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2006
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}Mark P Rubinstein, Marek Kovar, Jared F Purton, et al.
Vaccine|May 15, 2003
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2)Christophe L Nguyen, Mohamed L Salem, Mark P Rubinstein, et al.
Oncoimmunology|July 29, 2016
Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapyC Bryce Johnson, John Wrangle, Shikhar Mehrotra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidityMark P Rubinstein, Andre N Kadima, Mohamed L Salem, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cellsMohamed L Salem, Andre N Kadima, Sabry A El-Naggar, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
The lymphopenic environment of CD132 (common gamma-chain)-deficient hosts elicits rapid homeostatic proliferation of naive T cells via IL-15Chris Ramsey, Mark P Rubinstein, David M Kim, et al.
The Journal of Experimental Medicine|April 11, 2007
Antiviral CD4+ memory T cells are IL-15 dependentJared F Purton, Joyce T Tan, Mark P Rubinstein, et al.
Cancer|January 10, 2018
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicineJenny M Riley, Ashley W Cross, Chrystal M Paulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cellsMark P Rubinstein, Andre N Kadima, Mohamed L Salem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2003
CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cellJeffrey J Roszkowski, David C Yu, Mark P Rubinstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2006
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}Mark P Rubinstein, Marek Kovar, Jared F Purton, et al.
Vaccine|May 15, 2003
Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2)Christophe L Nguyen, Mohamed L Salem, Mark P Rubinstein, et al.
Oncoimmunology|July 29, 2016
Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapyC Bryce Johnson, John Wrangle, Shikhar Mehrotra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidityMark P Rubinstein, Andre N Kadima, Mohamed L Salem, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 2, 2007
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cellsMohamed L Salem, Andre N Kadima, Sabry A El-Naggar, et al.
Pageof 8